(Q47300367)

English

Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study

scientific article published on 20 February 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Michael Poyurovsky

1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

Camil Fuchs

2

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

Artashez Pashinian

3

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

Aya Levi

4

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

Sarit Faragian

5

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

Rachel Maayan

6

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

Irit Gil-Ad

7

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

publication date

20 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

192

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

3

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

441-448

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

https://scigraph.springernature.com/pub.10.1007/s00213-007-0731-1

0 references

Weight gain associated with the alpha2a-adrenergic receptor -1,291 C/G polymorphism and olanzapine treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0731-1

21 January 2018

Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic drug interactions with new psychotropic agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for drug-induced akathisia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Norepinephrine- and epinephrine-deficient mice gain weight normally on a high-fat diet.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy of reboxetine in major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic drug-induced weight gain: development of an animal model

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot study of the G-protein beta3 subunit gene (C825T) polymorphism and clinical response to olanzapine or olanzapine-related weight gain in persons with schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for extrapyramidal side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolic effects of antipsychotic medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/17310385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-007-0731-1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17310385

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47300367&oldid=2151300759"